ow dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after aortic arch surgery: a randomised controlled trial
Not Applicable
- Conditions
- acute kidney injury
- Registration Number
- JPRN-UMIN000011650
- Lead Sponsor
- Kawasaki Saiwai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 43
Inclusion Criteria
Not provided
Exclusion Criteria
1)an additional procedure was planned or undertaken 2)the arterial or venous cannulation sites were modified 3)the patient required an ANP infusion to treat perioperative acute heart failure 4)the patient age under 20 years 5)the patient had a history of adverse reaction to atrial natriuretic peptide 6)mean arterial blood pressure could not be maintained above 50 mmHg despite the administration of a positive inotrope or vasopressor after weaning from cardiopulmonary bypass.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end point was the incidence of AKI within 48 hours after surgery.
- Secondary Outcome Measures
Name Time Method